article thumbnail

Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low

Drug Channels

Among them: manufacturers’ evolving market access strategies, which increasingly aim to offset—or circumvent—growing pricing pressure from both commercial and government payers. Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

article thumbnail

2024 Gross-to-Net Realities at 9 Top Drugmakers: A New Era of Market Access

Drug Channels

As I noted in last week’s gross-to-net bubble analysis , manufacturers’ evolving market access strategies increasingly aim to offset—or circumvent—growing pricing pressure from both commercial and government payers. Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Informa Connect’s Medicaid Drug Rebate Program Summit

Drug Channels

Join 700 annual attendees and nearly 100 expert speakers to master complex regulatory guidelines to deliver compliant government pricing and reporting programs. Fireside Chats where an expert panel of attorneys discuss the most pressing issues facing MDRP and Government Pricing. All rights reserved.

article thumbnail

Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws (rerun)

Drug Channels

Should we continue down the path of government-mandated reporting, or should plan sponsors be left to negotiate their own deals? Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Lawmakers got to pat themselves on the back for “transparency,” but the data tell a different story.

article thumbnail

Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws

Drug Channels

Should we continue down the path of government-mandated reporting, or should plan sponsors be left to negotiate their own deals? Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Click here to learn more and sign up.

article thumbnail

At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs

Drug Channels

To learn more, register for Kalderos’ August 21, 2024, webinar: Revolutionizing Government Discount Programs: Why Traditional Methods Fail. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. He then explains Oregon’s novel approach to fixing the problem. Read on for Gavin’s insights.

article thumbnail

Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)

Drug Channels

The Inflation Reduction Acts changes to the Medicare Part D program, along with coming demographic shifts, will have a significant impact on future spending by government programs and consumers. Read more 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.